IDEAYA BIOSCIENCES INC's ticker is IDYA and the CUSIP is 45166A102. A total of 104 filers reported holding IDEAYA BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,280,297 | -24.2% | 232,776 | -34.0% | 0.00% | 0.0% |
| Q2 2023 | $8,285,303 | +564.9% | 352,566 | +288.5% | 0.00% | – |
| Q1 2023 | $1,246,024 | +18.0% | 90,752 | +56.2% | 0.00% | – |
| Q4 2022 | $1,055,985 | +44.3% | 58,117 | +18.5% | 0.00% | – |
| Q3 2022 | $732,000 | -38.3% | 49,032 | -43.0% | 0.00% | – |
| Q2 2022 | $1,186,000 | -12.3% | 86,055 | -28.8% | 0.00% | – |
| Q1 2022 | $1,352,000 | +46.0% | 120,839 | +208.3% | 0.00% | – |
| Q4 2021 | $926,000 | +32.7% | 39,193 | +43.1% | 0.00% | – |
| Q3 2021 | $698,000 | +187.2% | 27,383 | +136.9% | 0.00% | – |
| Q2 2021 | $243,000 | +3950.0% | 11,558 | +4903.5% | 0.00% | – |
| Q1 2021 | $6,000 | -96.4% | 231 | -98.1% | 0.00% | – |
| Q4 2020 | $167,000 | +187.9% | 11,950 | +159.3% | 0.00% | – |
| Q3 2020 | $58,000 | -39.6% | 4,609 | -31.4% | 0.00% | – |
| Q2 2020 | $96,000 | +4700.0% | 6,716 | +1181.7% | 0.00% | – |
| Q1 2020 | $2,000 | -71.4% | 524 | -41.8% | 0.00% | – |
| Q4 2019 | $7,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29,774,000 | 30.23% |
| Logos Global Management LP | 2,850,000 | $31,892,000 | 4.14% |
| 5AM Venture Management, LLC | 1,398,066 | $15,644,000 | 3.42% |
| ACT CAPITAL MANAGEMENT, LLC | 173,500 | $1,941,000 | 2.05% |
| DAFNA Capital Management LLC | 490,061 | $5,484,000 | 1.43% |
| Boxer Capital, LLC | 2,202,812 | $24,649,000 | 1.27% |
| BVF INC/IL | 1,600,559 | $17,910,000 | 0.72% |
| Avidity Partners Management LP | 2,690,000 | $30,101,000 | 0.63% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 62,929 | $704,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 109,000 | $1,623,000 | 0.37% |